Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun 30;58(2):112-115.
doi: 10.5045/br.2023.2022241. Epub 2023 May 10.

End of induction MRD assessment based early treatment intensification with novel agents in ETP-ALL- may be the way forward

Pritish Chandra Patra  1 , Sujay Rainchwar  1 , Reema Singh  1 , Rohan Halder  1 , Pallavi Mehta  1 , Megha Verma  1 , Rayaz Ahmed  1 , Jyoti Shankar Raichaudhuri  1 , Dinesh Bhurani  1 , Narendra Agrawal  1 , Suman Pramanik  2
Affiliations

End of induction MRD assessment based early treatment intensification with novel agents in ETP-ALL- may be the way forward

Pritish Chandra Patra et al. Blood Res. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Authors’ Disclosures of Potential Conflicts of Interest

No potential conflicts of interest relevant to this article were reported.

Figures

Fig. 1
Fig. 1
Consort flow diagram of patients and their outcomes.
Fig. 2
Fig. 2
Survival of the entire study population (N=11). (A) Median overall survival (OS) survival time: not reached (95% LCL, 27; 95% UCL, not reached). (B) Median progression free survival (PFS) survival time: not reached (95% LCL, 27; 95% UCL, not reached).
See this image and copyright information in PMC

References

    1. Borowitz MJ, Chan JKC, Downing JR, Le Beau MM, Arber DA. Precursor lymphoid neoplasms. In: Swerdlow SH, Campo E, Harris NL, et al, eds. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon, France: IARC. 2017:199–213. doi: 10.53347/rid-9250. - DOI
    1. Jain N, Lamb AV, O'Brien S, et al. Early T-cell precursor acute lymphoblastic leukemia/lymphoma (ETP-ALL/LBL) in adolescents and adults: a high-risk subtype. Blood. 2016;127:1863–9. doi: 10.1182/blood-2015-08-661702. - DOI - PMC - PubMed
    1. Zhang Y, Qian JJ, Zhou YL, et al. Comparison of early T-cell precursor and non-ETP subtypes among 122 Chinese adults with acute lymphoblastic leukemia. Front Oncol. 2020;10:1423. doi: 10.3389/fonc.2020.01423.04fa1d45900b4e4a84fe67e26e49d3d1 - DOI - PMC - PubMed
    1. Mirgh S, Ahmed R, Agrawal N, et al. Will daratumumab be the next game changer in early thymic precursor-acute lymphoblastic leukaemia? Br J Haematol. 2019;187:e33–5. doi: 10.1111/bjh.16154. - DOI - PubMed
    1. Bond J, Graux C, Lhermitte L, et al. Early response-based therapy stratification improves survival in adult early thymic precursor acute lymphoblastic leukemia: a group for research on adult acute lymphoblastic leukemia study. J Clin Oncol. 2017;35:2683–91. doi: 10.1200/JCO.2016.71.8585. - DOI - PubMed